Jessica M. Nielsen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jessica M. Nielsen has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Frederik Barkhof
Amsterdam UMC, Location VUmc
4 shared publications - Gilles Edan
Neurology Department, Rennes University Hospital, France
2 shared publications - Ludwig Kappos
University Hospital Basel, Switzerland
2 shared publications B. Moraal
Department of Radiology, VU University Medical Center, Amsterdam, The Netherlands
1 shared publicationB.M.J. Uitdehaag
Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands, Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands
1 shared publicationBernard M. J. Uitdehaag
Department of Neurology, VU University Medical Centre, Amsterdam, Netherlands
1 shared publication
Latest Publications
- Open Access
- 4 February 2011
- Published by Springer Nature in BMC Neurology
- Vol. 11 (1) , 19
Erratum to: Prognostic implications of a carefully performed neurological assessment in patients with a first event suggestive of multiple sclerosis
- 4 February 2011
- Published by Springer Nature in BMC Neurology
- Vol. 11 (1) , 19
Open AccessErratum to: Prognostic implications of a carefully performed neurological assessment in patients with a first event suggestive of multiple sclerosis
- Open Access
- 20 May 2009
- Published by Springer Nature in BMC Neurology
- Vol. 9 (1) , 19
MRI characteristics are predictive for CDMS in monofocal, but not in multifocal patients with a clinically isolated syndrome
To diagnose multiple sclerosis (MS), evidence for dissemination in space and time is required. There is no clear definition on how symptoms and signs of a patient indicate clinical dissemination in space. To provide a uniform approach on this subject, a clinical classification system was described recently differentiating patients with mono- and multifocal clinical presentation. Here we assess the predictive value of clinically defined dissemination in space at first presentation for time to clinically definite MS (CDMS).
- 20 May 2009
- Published by Springer Nature in BMC Neurology
- Vol. 9 (1) , 19
Open AccessMRI characteristics are predictive for CDMS in monofocal, but not in multifocal patients with a clinically isolated syndrome
To diagnose multiple sclerosis (MS), evidence for dissemination in space and time is required. There is no clear definition on how symptoms and signs of a patient indicate clinical dissemination in space. To provide a uniform approach on this subject, a clinical classification system was described recently differentiating patients with mono- and multifocal clinical presentation. Here we assess the predictive value of clinically defined dissemination in space at first presentation for time to clinically definite MS (CDMS).
- 1 July 2007
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 13 (6) , 717-721
Classification of patients with a clinically isolated syndrome based on signs and symptoms is supported by magnetic resonance imaging results
Background Recently, a clinical classification system was described to determine whether symptoms and signs of patients presenting with a first episode suggestive of multiple sclerosis (MS) indicate the presence of monofocal or multifocal disease. Objectives To evaluate the value of this new classification system by comparing the results with those of simultaneously obtained magnetic resonance imaging (MRI) scans. Methods The 487 patients, randomised in the BENEFIT study, were centrally assessed using the new system and classified as monofocal or multifocal, based on clinical information by two neurologists masked for the MRI results. MRI analyses were performed by expert readers masked for the clinical classification. Results Patients classified as multifocal had more T2 hyperintense (median: 21 versus 15.5) and more T1 hypo-intense lesions (median: 2 versus 1) than those classified as monofocal. Patients classified at the local site as having evidence of a single clinical lesion, but reclassified centrally as having a clinical multifocal central nervous system presentation, had more T2 lesions than monofocal patients. In addition, patients with a multifocal presentation more often fulfilled the MRI criteria for dissemination in space, as incorporated in the International Panel (IP) diagnostic criteria for MS. Conclusion These data provide justification for the recently proposed clinical classification system to be used in patients who present with a first episode suggestive of MS, in that `multifocal', based on symptoms and signs, is associated with more lesions on MRI. Multiple Sclerosis 2007; 13: 717-721. http://msj.sagepub.com
- 1 July 2007
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 13 (6) , 717-721
Classification of patients with a clinically isolated syndrome based on signs and symptoms is supported by magnetic resonance imaging results
Background Recently, a clinical classification system was described to determine whether symptoms and signs of patients presenting with a first episode suggestive of multiple sclerosis (MS) indicate the presence of monofocal or multifocal disease. Objectives To evaluate the value of this new classification system by comparing the results with those of simultaneously obtained magnetic resonance imaging (MRI) scans. Methods The 487 patients, randomised in the BENEFIT study, were centrally assessed using the new system and classified as monofocal or multifocal, based on clinical information by two neurologists masked for the MRI results. MRI analyses were performed by expert readers masked for the clinical classification. Results Patients classified as multifocal had more T2 hyperintense (median: 21 versus 15.5) and more T1 hypo-intense lesions (median: 2 versus 1) than those classified as monofocal. Patients classified at the local site as having evidence of a single clinical lesion, but reclassified centrally as having a clinical multifocal central nervous system presentation, had more T2 lesions than monofocal patients. In addition, patients with a multifocal presentation more often fulfilled the MRI criteria for dissemination in space, as incorporated in the International Panel (IP) diagnostic criteria for MS. Conclusion These data provide justification for the recently proposed clinical classification system to be used in patients who present with a first episode suggestive of MS, in that `multifocal', based on symptoms and signs, is associated with more lesions on MRI. Multiple Sclerosis 2007; 13: 717-721. http://msj.sagepub.com
- 1 March 2007
- Vol. 14 (1) , 29-34
Diagnosing MS: recent guidelines and future goals focusing on magnetic resonance imaging.
Previous diagnostic guidelines for MS relied largely on clinical evidence and cerebrospinal fluid analysis. In 2001, guidelines were published that allowed partial substitution of the required clinical evidence by magnetic resonance imaging findings and defined primary progressive multiple sclerosis (PPMS). Recently, revised guidelines on MS diagnosis were published, mainly to improve definitions of dissemination in space (using spinal cord imaging) and in time (using T2 lesions), enabling a faster and more accurate MS diagnosis. Criteria for PPMS were also revised. Current research is concentrating on the definition of uniform clinical terms, to allow a more standardized diagnosis, and aims to simplify the criteria while improving diagnostic accuracy.
- 1 March 2007
- Vol. 14 (1) , 29-34
Diagnosing MS: recent guidelines and future goals focusing on magnetic resonance imaging.
Previous diagnostic guidelines for MS relied largely on clinical evidence and cerebrospinal fluid analysis. In 2001, guidelines were published that allowed partial substitution of the required clinical evidence by magnetic resonance imaging findings and defined primary progressive multiple sclerosis (PPMS). Recently, revised guidelines on MS diagnosis were published, mainly to improve definitions of dissemination in space (using spinal cord imaging) and in time (using T2 lesions), enabling a faster and more accurate MS diagnosis. Criteria for PPMS were also revised. Current research is concentrating on the definition of uniform clinical terms, to allow a more standardized diagnosis, and aims to simplify the criteria while improving diagnostic accuracy.
- 20 October 2005
- Published by Wiley in Annals of Neurology
- Vol. 58 (5) , 781-783
Overdiagnosis of multiple sclerosis and magnetic resonance imaging criteria
Retrospectively, we assessed the specificity of two proposed magnetic resonance imaging (MRI) criteria for multiple sclerosis (MS) in patients suspected to have MS but who ultimately receive another diagnosis. Brain MRIs of 28 patients mixed with 28 MRIs of MS patients from the same cohort of 377 consecutively referred patients were scored by a neuroradiologist masked to the final diagnosis. The criteria for dissemination in space incorporated in the McDonald International Panel showed good specificity (89%). However, the more sensitive criteria proposed by a Subcommittee of the American Academy of Neurology resulted in a lower specificity (29%), indicating an increased risk of a false‐positive diagnosis. Ann Neurol 2005;58:781–783
- 20 October 2005
- Published by Wiley in Annals of Neurology
- Vol. 58 (5) , 781-783
Overdiagnosis of multiple sclerosis and magnetic resonance imaging criteria
Retrospectively, we assessed the specificity of two proposed magnetic resonance imaging (MRI) criteria for multiple sclerosis (MS) in patients suspected to have MS but who ultimately receive another diagnosis. Brain MRIs of 28 patients mixed with 28 MRIs of MS patients from the same cohort of 377 consecutively referred patients were scored by a neuroradiologist masked to the final diagnosis. The criteria for dissemination in space incorporated in the McDonald International Panel showed good specificity (89%). However, the more sensitive criteria proposed by a Subcommittee of the American Academy of Neurology resulted in a lower specificity (29%), indicating an increased risk of a false‐positive diagnosis. Ann Neurol 2005;58:781–783